Multicenter, Platform-type Clinical Study of Refractory/Recurrent Acute Myeloid Leukemia
Multicenter, Platform-type Clinical Study of Refractory/Recurrent Acute Myeloid Leukemia
Recruiting · NCT06265545 · Registry updated 2026-08-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Multicenter, Platform-type Clinical Study of Refractory/Recurrent Acute Myeloid Leukemia | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, acute myeloid leukemia | Recruiting | Not applicable | 2026-08-07 | NCT06265545 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 285 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Blood Hospital | Tianjin | China | 1 |